Help power Marketplace this winter when you support the show today. Donate Now!

The push to revive limits on the abortion pill

Oct 25, 2024
In this week's newsletter, we’re looking at how states are reviving lawsuits to block mail-order abortion pills, the FTC's new rule that promised to curtail fake consumer reviews, and we do the numbers on down payment assistance programs.
Photo illustration by Anna Moneymaker/Getty Images

Report on toxic metals in tampons draws attention to regulation of period products

Jul 15, 2024
Researchers found "measurable" but low amounts of metals like lead and arsenic in all of the tampons they tested.
"There are no requirements at the FDA level that limit the kind of chemicals that can be present in menstrual products directly," said  Bobbi Wilding of Clean and Healthy, an advocacy group.
Loic Venance/AFP via Getty Images

American sunscreens lag behind Korean brands in quality. Why?

Jul 8, 2024
The FDA hasn't approved a new UV filter for sunscreen since 1999. Some consumers are turning to foreign markets instead.
American sunscreens are notoriously thick and greasy. Some countries have more advanced options.
Michel Porro/Getty Images)

In the fight against food fraud, producers are getting high-tech

Nov 22, 2023
Between edible microchips, invisible ink and more, the food supply chain is becoming more transparent than ever.
High end foods such as caviar, regional cheese and wines are trying new methods to thwart dupes.
Justin Sullivan/Getty Images

Cultivated meat is on the horizon, but has long way to go before it hits grocery shelves

Mar 24, 2023
The FDA has approved a chicken product grown this way by California-based company Good Meat. It’s only the second company to get that agency’s green light.
The Food and Drug Administration recently approved a cultivated chicken meat grown by California-based Good Meat.
Sarah Silbiger/Getty Images

Medicare rejected a controversial Alzheimer's drug. Participants still ended up paying for it.

Oct 24, 2022
Medicare raised premiums late last year in preparation to cover the drug Aduhelm. Ultimately, Medicare rejected coverage of the drug, with limited exceptions.
Biogen initially priced its Alzheimer’s treatment drug at $56,000 a year. That figure was factored in when Medicare set Part B premiums late last year.
Dominick Reuter/AFP via Getty Images

FDA rule clears hearing aids for over-the-counter sale

Aug 17, 2022
The hope is that over-the-counter sales could make the devices more affordable to millions of Americans who would benefit from them.
Many people who need hearing aids don't have them because of the high cost — about $5,000, which insurance often doesn't cover.
Joe Raedle/Getty Images

For public good, not for profit.

Why the U.S. doesn't have the best sunscreens in the world

Jul 13, 2022
The FDA hasn't approved ingredients that could make products more pleasing to use — and used more often, says Amanda Mull of The Atlantic.
People may be less likely to use sunscreen when it feels sticky, goopy or greasy, or leaves a white cast.
Mykola Sosiukin/Getty Images

Daily Harvest recall raises concerns about the need for more food regulation 

Jun 30, 2022
The first lawsuit has been filed against Daily Harvest, which is facing complaints from hundreds of consumers who reported falling ill after eating one of the company’s products.
A view of lentils atop a wooden table. Hundreds of consumers say they've gotten ill after consuming a Daily Harvest product containing lentils and leeks.
Karisssa/iStock/Getty Images Plus

Medicare proposes limiting coverage of controversial Alzheimer's drug

Jan 13, 2022
Government insurer won't cover Aduhelm's $28,000-a-year price tag except for clinical trials.
A sign for biotechnology company, Biogen, Inc. is seen on a building in Cambridge, Massachusetts.
DOMINICK REUTER/AFP via Getty Images